The startup aims to reimagine the decision-making process for cancer treatment using histology-based biomarkers gleaned from digitized images of histology slides.
We can’t check out every investing outfit’s demo day. But one event that we try to catch every year is that of Pear, which is held annually each fall and features (blessedly) just a dozen or so very nascent startups. Pear, a seed-stage venture firm founded in 2013, has an impressive track record when it […]